A detailed history of Orbimed Advisors LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,406,335 shares of NPCE stock, worth $37.9 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
3,406,335
Previous 3,406,335 -0.0%
Holding current value
$37.9 Million
Previous $25.8 Million 7.8%
% of portfolio
0.56%
Previous 0.62%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.38 - $15.33 $3.81 Million - $9.16 Million
-597,632 Reduced 14.93%
3,406,335 $25.8 Million
Q4 2023

Feb 14, 2024

SELL
$5.9 - $10.31 $49,052 - $85,717
-8,314 Reduced 0.21%
4,003,967 $41.3 Million
Q2 2021

Aug 16, 2021

BUY
$19.03 - $26.5 $76.4 Million - $106 Million
4,012,281 New
4,012,281 $95.5 Million

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $277M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.